Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
TSTL

Tristel plc

TSTLLSEUnited KingdomHealthcareMedical Instruments & SuppliesFTSE AIM 100

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

P/E25.56xP/B5.82xROIC26.2%Dividend yield3.5%
£196.62M
Market Cap
EV: £187.81M
MOM6
QUAL10
VAL4
RSK3
TSTL
£196.62M
Market Cap · EV £187.81M

Tristel plc

MOM6
QUAL10
VAL4
RSK3

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other.…more

Latest RNS from Tristel plc

All TSTL news → · RNS daily feed

Analyst consensus: Buy

As of 6 Oct 2026, 6 analysts rate Tristel plc a Buy, with 83% buy ratings and a mean price target of 475p (range 400p–560p), +16% vs the current price.

Strong buy: 0Buy: 5Hold: 1Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 261p against a current price of 424p (-38%), based on EV/EBITDA.

More Healthcare companies